It promotes the assembly and activation of NLRP3 complexes by activating the mitogen-activated protein kinase (MAPK)/NF-κB signaling pathway, thereby exacerbating TAC-induced pathological cardiac hypertrophy and dysfunction (105). The gene discussed is NLRP3; the disease is cardiac hypertrophy.